RELMADA THERAPEUTICS, INC. Public Float
RELMADA THERAPEUTICS, INC. (RLMD) had Public Float of $18.89 million as of 2025-06-30, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-19
- 2025-06-30: Entity Public Float $18.89M.
- 2024-06-30: Entity Public Float $89.01M.
- 2023-06-30: Entity Public Float $72.95M.
- 2022-06-30: Entity Public Float $562.98M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $18.89M 10-K · filed 2026-03-19 |
| 2024-06-30 | $89.01M 10-K · filed 2025-03-27 |
| 2023-06-30 | $72.95M 10-K · filed 2024-03-19 |
| 2022-06-30 | $562.98M 10-K · filed 2023-03-23 |
| 2021-06-30 | $547.45M 10-K · filed 2022-03-25 |
| 2020-06-30 | $694.98M 10-K · filed 2021-03-24 |
| 2019-06-30 | $70.13M 10-KT · filed 2020-03-26 |
| 2018-12-31 | $9.41M 10-K · filed 2019-09-24 |
| 2017-12-31 | $9.41M 10-K · filed 2018-09-28 |
| 2016-12-31 | $11.03T 10-K · filed 2017-09-28 |
| 2016-06-30 | $0.00 10-K · filed 2016-09-09 |
| 2014-12-31 | $127.03M 10-K · filed 2015-09-11 |
| 2013-12-31 | $0.00 10-KT · filed 2014-09-09 |
| 2013-12-13 | $0.00 10-K · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |